The drug melatonin, a potent antioxidant and growth modulator, was identified as a promising candidate for the topical treatment of hair loss. The study was conducted in 2003 at the Forenap Centre Hospitalier in Rouffach, France. The drug was found to be well tolerated. Approximately 80% of people found that it reduced hair loss during the short 90 day trial. The study concluded that there was a positive effect of melatonin on hair growth in patients with AGA. The authors recommended more studies have to be done to confirm the benefits for both short and long term hair loss treatment. The drug melatonin may behave similar to a topical drug which was marketed by a French pharmaceutical company which was known as a “morning after” abortion pill (as it was/is known and marketed some 20 years ago) and no longer on the market. A topical form of melatonin is commercialized in Spain (a topical solution called Lambdapil solution) but according to a colleague there, it is weak and no better than minoxidil.
https://newhair.com/wp-content/uploads/2018/06/nhi-medical-356px.png 0 0 William Rassman, M.D. https://newhair.com/wp-content/uploads/2018/06/nhi-medical-356px.png William Rassman, M.D.2015-01-22 07:21:282015-01-20 11:21:54Interesting Topical Medication For Hair Loss